GTH Profile
Genetron Holdings Ltd (GTH) is a biotechnology company focused on the development and commercialization of precision oncology solutions. The company provides a range of products and services, including cancer molecular profiling, early screening and detection, companion diagnostics, and clinical trials support. Genetron's technology platform includes next-generation sequencing (NGS) and artificial intelligence (AI) algorithms to analyze genomic data and identify potential biomarkers for cancer diagnosis, treatment, and monitoring. The company's products and services are used by healthcare providers, biopharmaceutical companies, and research institutions. Genetron is headquartered in Beijing, China, and as of September 2021, had a market capitalization of approximately $1.1 billion.
|
